Scientists at the University of Birmingham have developed an eye drop for treating age-related macular degeneration (AMD), helping to eliminate the need for painful injections into the eye.
Researchers have reportedly invented a method of delivering the injected drug currently used to treat AMD, which carry an increased risk of complications, as an eye drop instead. And according to researchers, their laboratory research has obtained the same outcomes as the injected drug.
The eye drop reportedly uses a cell-penetrating peptide (CPP) to deliver the drug to the relevant part of the eye within minutes. Researchers believe a self-administering drug application such as the eye drop would help empower patients and reduce treatment costs.
The research was recently published in the journal Investigative Ophthalmology and Visual Science.
Click here to read the full press release.
Like what you read? Follow OptometryWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
Source: University of Birmingham